# Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV

> **NCT07390474** · PHASE1 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 40 (estimated)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** DV201P-RNA
- **BIOLOGICAL:** DV202B1-RNA

## Key facts

- **NCT ID:** NCT07390474
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-25
- **Primary completion:** 2027-12-14
- **Final completion:** 2027-12-14
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07390474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07390474, "Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07390474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*